New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 5, 2014
10:45 EDTEXPE, PEIX, WTW, TWTR, MACKOptions with decreasing implied volatility: MACK WTW EXPE TWTR PEIX
News For MACK;WTW;EXPE;TWTR;PEIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 22, 2015
13:11 EDTTWTRTwitter higher in volatile trading, levels to watch
Subscribe for More Information
10:39 EDTTWTRTwitter active call volume attributed to takeover speculation
Subscribe for More Information
10:29 EDTTWTRRumor: Twitter strength attributed to takeover speculation
Subscribe for More Information
06:15 EDTTWTRTwitter rolls out 'while you were away' feature
Twitter announced on its blog that it is rolling out a "while you were away feature," or "a recap of some of the top Tweets you might have missed from accounts you follow... Our goal is to help you keep up – or catch up – with your world, no matter how much time you spend on Twitter. With a few improvements to the home timeline we think we can do a better job of delivering on that promise without compromising the real time nature of Twitter. Recaps, marked with a 'While you were away' heading, will begin to appear for all Twitter for iOS users today, and on our Android app and twitter.com soon." Reference Link
January 21, 2015
16:00 EDTTWTROptions Update; January 21, 2015
iPath S&P 500 VIX Short-Term Futures down 1.63 to 33.49. Option volume leaders: AAPL TSLA TWTR AMZN FB RIG C ABX SIRI NFLX according to Track Data.
January 20, 2015
16:00 EDTTWTROptions Update; January 20, 2015
iPath S&P 500 VIX Short-Term Futures down 36c to 35.12 Option volume leaders: AAPL TSLA TWTR GILD NFLX MGM ABX AMAT JNJ C according to Track Data.
15:24 EDTTWTREarnings Preview: IBM estimates cut by Jefferies, BofA ahead of report
Subscribe for More Information
14:09 EDTEXPEOrbitz jumps after Bloomberg says company may be exploring sale
Shares of online travel agency Orbitz Worldwide (OWW) are jumping after Bloomberg reported that the company is exploring the possibility of selling itself. In a note to investors on January 7, research firm FBR Capital wrote that the company could be acquired for over $10 per share, WHAT'S NEW: Orbitz is exploring a potential sale and private equity firms have expressed interest in acquiring the online travel agency, Bloomberg reported today. ANALYST VIEW: On January 7, research firm FBR Capital estimated that Orbitz could be acquired for $10.27 per share. The firm noted that a trade publication, Tnooz.com, had reported that Orbitz could be considering selling itself. Expedia (EXPE) and Priceline (PCLN) could each pay a premium of 30%-plus for Orbitz and still see their profits rise from the acquisition, FBR added. It kept a $9 price target and Outperform rating on Orbitz. PRICE ACTION: In mid-afternoon trading, Orbitz climbed 69c, or 7.5%, to $9.85.
13:51 EDTEXPEOrbitz draws private equity interest as sale explored, Bloomberg says
Orbitz Worldwide (OWW) is working with an adviser to contact potential buyers and has drawn interest from private-equity funds and "other Internet companies," according to Bloomberg, citing people with knowledge of the matter. Shares of Orbitz are up over 10% after the report, while several other names in the online travel space, such as Priceline (PCLN), Expedia (EXPE), and TripAdvisor (TRIP) are also moving. Reference Link
13:43 EDTEXPEExpedia, TripAdvisor tick higher after report on Orbitz sale exploration
Subscribe for More Information
08:16 EDTMACKMerrimack data of Phase 3 MM-398 NAPOLI-1 study supports development programs
Merrimack Pharmaceuticals (MACK) announced that additional analyses were presented on January 16, 2015 from the Phase 3 NAPOLI-1 study of MM-398, also known as nal-IRI, in patients with metastatic pancreatic cancer previously treated with gemcitabine-based therapy. Merrimack and Baxter International's (BAX) biopharmaceutical business are collaborating on the development and commercialization of MM-398 outside of the United States and Taiwan. PharmaEngine holds the rights to commercialize MM-398 in Taiwan. Additionally, Merrimack presented preclinical and clinical data from studies of its investigational agents MM-141 and MM-151 in pancreatic and colorectal cancer, respectively. An investigator-sponsored study of MM-398 in colorectal cancer was also presented. The extended analyses for the global NAPOLI-1 Phase 3 trial presented at ASCO GI support the robustness of the overall survival benefit of MM-398 in combination with 5-fluorouracil, or 5-FU, and leucovorin presented in June 2014, at the European Society for Medical Oncology World Congress on Gastrointestinal Cancer, or ESMO GI. The primary analysis, presented at ESMO GI, demonstrated a statistically significant advantage in overall survival with an unstratified hazard ratio of 0.67, and a median of 6.1 months for the combination of MM-398 plus 5-FU and leucovorin compared to 4.2 months in the control arm.
05:57 EDTTWTRTwitter acquires ZipDial, terms not disclosed
Twitter said in a blog entry that the company has agreed to acquire ZipDial a product partner based in Bangalore, India, "to make Twitter even more accessible to people around the world. Over the next several years, billions of people will come online for the first time in countries like Brazil, India and Indonesia. For many, their first online experience will be on a mobile device – but the cost of data may prevent them from experiencing the true power of the Internet. Twitter, in partnership with ZipDial, can make great content more accessible to everyone... This acquisition significantly increases our investment in India, one of the countries where we’re seeing great growth, and also brings us a new engineering office in Bangalore." Terms of the deal have not been disclosed.
January 16, 2015
16:00 EDTTWTROptions Update; January 16, 2015
Subscribe for More Information
11:05 EDTTWTRStocks with call strike movement; TWTR SUNE
Subscribe for More Information
09:37 EDTTWTRActive equity options trading
Subscribe for More Information
08:44 EDTEXPEExpedia may have to pay $180M for Travelocity, says FBR Capital
Subscribe for More Information
07:21 EDTEXPESabre sale of Travelocity to Expedia would be win for both, says Oppenheimer
Subscribe for More Information
January 15, 2015
16:01 EDTTWTROptions Update; January 15, 2015
iPath S&P 500 VIX Short-Term Futures up 1.01 to 36.13. Option volume leaders: AAPL TSLA TWTR AMZN FB C CLF ABX SUNE according to Track Data.
07:59 EDTMACKAmerican Society of Clinical Oncology to hold a symposium
Subscribe for More Information
07:25 EDTWTWWeight Watchers price target lowered to $20 from $24 at Credit Suisse
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use